Inventor · disambiguated record
Chaofeng Long
Also filed as: LONG CHAOFENG
17 granted patents·3 pending applications·38 citations·filing 2015–2025
89Inventor score
Top patents by PatentIndex Score
20 records- 0193US11725009B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2021·Granted Aug 15, 2023·2 cites·17 claims
- 0290US11535613B2Crystal form and salt form of pyridoimidazole compound and preparation method thereforGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2019·Granted Dec 27, 2022·6 cites·25 claims
- 0390US9938292B2Quinoline derivatives as SMO inhibitorsGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·19 cites·20 claims
- 0489US11136319B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Oct 5, 2021·4 cites·19 claims
- 0582US12319692B2Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·17 claims
- 0679US10526320B2Pyrrolidine derivatives as PPAR agonistsGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Jan 7, 2020·2 cites·20 claims
- 0779US10278973B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 7, 2019·2 cites·10 claims
- 0879US2025250275A1Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 0973US11008292B2FGFR4 inhibitor and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2017·Granted May 18, 2021·1 cites·15 claims
- 1071US10399981B2Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseasesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 1168US10654808B2Tyrosine kinase inhibitor and pharmaceutical composition comprising sameGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 19, 2020·1 cites·21 claims
- 1260US2024287043A1Ketoamide derivative and application thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1357US2024270810A1Preparation and application of polypeptideGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1455USRE49128EHydroxyl purine compounds and applications thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2015·Granted Jul 12, 2022·0 cites·22 claims
- 1551US11440903B2Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 13, 2022·0 cites·26 claims
- 1644US10098885B2Hydroxyl purine compounds and applications thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·0 cites·19 claims
- 1742US10766862B2Crystal form and salt form of and preparation method for tyrosine kinase inhibitorGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Sep 8, 2020·0 cites·15 claims
- 1841US10618898B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Apr 14, 2020·0 cites·14 claims
- 1940US12252487B2Dominant salt forms of pyrimidine derivatives, and crystal forms thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2020·Granted Mar 18, 2025·0 cites·14 claims
- 2032US10532053B2Histone deacetylase inhibitor, and preparation method and use thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 14, 2020·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Chaofeng Long files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →